Marshall Wace’s Strata Critical Medical, Inc. Class A Common Stock SRTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $581K | Buy |
+144,167
| New | +$581K | ﹤0.01% | 1962 |
|
|
2025
Q1 | – | Sell |
-452,445
| Closed | -$1.92M | – | 2481 |
|
|
2024
Q4 | $1.92M | Buy |
452,445
+356,596
| +372% | +$1.52M | ﹤0.01% | 1346 |
|
|
2024
Q3 | $282K | Buy |
+95,849
| New | +$282K | ﹤0.01% | 2008 |
|
|
2024
Q2 | – | Sell |
-21,314
| Closed | -$60.7K | – | 2313 |
|
|
2024
Q1 | $60.7K | Buy |
+21,314
| New | +$60.7K | ﹤0.01% | 2046 |
|
|
2023
Q2 | – | Sell |
-12,133
| Closed | -$41K | – | 2035 |
|
|
2023
Q1 | $41K | Buy |
+12,133
| New | +$41K | ﹤0.01% | 2044 |
|
|
2021
Q4 | – | Sell |
-113,237
| Closed | -$1.18M | – | 3168 |
|
|
2021
Q3 | $1.18M | Buy |
113,237
+3,070
| +3% | +$31.9K | ﹤0.01% | 1485 |
|
|
2021
Q2 | $1.16M | Buy |
+110,167
| New | +$1.16M | 0.01% | 1346 |
|
|
2021
Q1 | – | Sell |
-851,708
| Closed | -$9.44M | – | 2129 |
|
|
2020
Q4 | $9.44M | Buy |
851,708
+351,710
| +70% | +$3.9M | 0.05% | 337 |
|
|
2020
Q3 | $5.03M | Buy |
+499,998
| New | +$5.03M | 0.03% | 489 |
|